Cardiac Involvement in Women With Pathogenic Dystrophin Gene Variants

Objective: To determine the frequency and extent of cardiac involvement in female carriers of pathogenic variants in DMD, 53 women were examined through an observational, cross-sectional study.Methods: Genetically verified female carriers of pathogenic DMD variants were examined by cardiac magnetic...

Full description

Bibliographic Details
Main Authors: Tuva Å. Solheim, Freja Fornander, Anna A. Raja, Rasmus Møgelvang, Nanna S. Poulsen, Morten Dunø, Henning Bundgaard, John Vissing
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.707838/full
_version_ 1818618297282723840
author Tuva Å. Solheim
Freja Fornander
Anna A. Raja
Rasmus Møgelvang
Nanna S. Poulsen
Morten Dunø
Henning Bundgaard
John Vissing
author_facet Tuva Å. Solheim
Freja Fornander
Anna A. Raja
Rasmus Møgelvang
Nanna S. Poulsen
Morten Dunø
Henning Bundgaard
John Vissing
author_sort Tuva Å. Solheim
collection DOAJ
description Objective: To determine the frequency and extent of cardiac involvement in female carriers of pathogenic variants in DMD, 53 women were examined through an observational, cross-sectional study.Methods: Genetically verified female carriers of pathogenic DMD variants were examined by cardiac magnetic resonance imaging (CMR) with late gadolinium enhancement, echocardiography, 24-h Holter monitoring, ECG, and blood concentrations of skeletal and cardiac muscle biomarkers.Results: Fifty-three female carriers of pathogenic DMD variants (mean age 49.6 years, 33 associated with DMD, and 20 with BMD) were included in the study. Sixty-two percent had cardiac dysfunction on echocardiography. On CMR, 49% had myocardial fibrosis, 35% had dilated left ventricles, and 10% had left ventricular hypertrophy. ECGs were abnormal in 72%, and abnormal Holter monitoring was found in 43%. Age did not correlate with myocardial fibrosis or cardiac dysfunction. Myocardial fibrosis was more frequent in carriers of pathogenic variants associated with DMD vs. BMD (61 vs. 28%, p = 0.02).Conclusion: This study shows that cardiac involvement, affecting both structure and function of the heart, is found in over 2/3 of women with a pathogenic DMD variant. The study supports early cardiac screening, including ECG, Holter, and cardiac imaging, in this group of carriers, so that symptoms related to pathogenic variants in DMD can be recognized, and relevant treatment can be initiated. Longitudinal studies are needed to assess morbidity and mortality related to single, pathogenic DMD variants in women.
first_indexed 2024-12-16T17:19:21Z
format Article
id doaj.art-a5bbe2353054441c96e810a8952916c8
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-16T17:19:21Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-a5bbe2353054441c96e810a8952916c82022-12-21T22:23:13ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-07-011210.3389/fneur.2021.707838707838Cardiac Involvement in Women With Pathogenic Dystrophin Gene VariantsTuva Å. Solheim0Freja Fornander1Anna A. Raja2Rasmus Møgelvang3Nanna S. Poulsen4Morten Dunø5Henning Bundgaard6John Vissing7Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkDepartment of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkDepartment of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkDepartment of Clinical Genetics, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkDepartment of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkObjective: To determine the frequency and extent of cardiac involvement in female carriers of pathogenic variants in DMD, 53 women were examined through an observational, cross-sectional study.Methods: Genetically verified female carriers of pathogenic DMD variants were examined by cardiac magnetic resonance imaging (CMR) with late gadolinium enhancement, echocardiography, 24-h Holter monitoring, ECG, and blood concentrations of skeletal and cardiac muscle biomarkers.Results: Fifty-three female carriers of pathogenic DMD variants (mean age 49.6 years, 33 associated with DMD, and 20 with BMD) were included in the study. Sixty-two percent had cardiac dysfunction on echocardiography. On CMR, 49% had myocardial fibrosis, 35% had dilated left ventricles, and 10% had left ventricular hypertrophy. ECGs were abnormal in 72%, and abnormal Holter monitoring was found in 43%. Age did not correlate with myocardial fibrosis or cardiac dysfunction. Myocardial fibrosis was more frequent in carriers of pathogenic variants associated with DMD vs. BMD (61 vs. 28%, p = 0.02).Conclusion: This study shows that cardiac involvement, affecting both structure and function of the heart, is found in over 2/3 of women with a pathogenic DMD variant. The study supports early cardiac screening, including ECG, Holter, and cardiac imaging, in this group of carriers, so that symptoms related to pathogenic variants in DMD can be recognized, and relevant treatment can be initiated. Longitudinal studies are needed to assess morbidity and mortality related to single, pathogenic DMD variants in women.https://www.frontiersin.org/articles/10.3389/fneur.2021.707838/fulldystrophinopathyfemale carrierscardiac MRIechocardiographycardiaccardiac involvement
spellingShingle Tuva Å. Solheim
Freja Fornander
Anna A. Raja
Rasmus Møgelvang
Nanna S. Poulsen
Morten Dunø
Henning Bundgaard
John Vissing
Cardiac Involvement in Women With Pathogenic Dystrophin Gene Variants
Frontiers in Neurology
dystrophinopathy
female carriers
cardiac MRI
echocardiography
cardiac
cardiac involvement
title Cardiac Involvement in Women With Pathogenic Dystrophin Gene Variants
title_full Cardiac Involvement in Women With Pathogenic Dystrophin Gene Variants
title_fullStr Cardiac Involvement in Women With Pathogenic Dystrophin Gene Variants
title_full_unstemmed Cardiac Involvement in Women With Pathogenic Dystrophin Gene Variants
title_short Cardiac Involvement in Women With Pathogenic Dystrophin Gene Variants
title_sort cardiac involvement in women with pathogenic dystrophin gene variants
topic dystrophinopathy
female carriers
cardiac MRI
echocardiography
cardiac
cardiac involvement
url https://www.frontiersin.org/articles/10.3389/fneur.2021.707838/full
work_keys_str_mv AT tuvaasolheim cardiacinvolvementinwomenwithpathogenicdystrophingenevariants
AT frejafornander cardiacinvolvementinwomenwithpathogenicdystrophingenevariants
AT annaaraja cardiacinvolvementinwomenwithpathogenicdystrophingenevariants
AT rasmusmøgelvang cardiacinvolvementinwomenwithpathogenicdystrophingenevariants
AT nannaspoulsen cardiacinvolvementinwomenwithpathogenicdystrophingenevariants
AT mortendunø cardiacinvolvementinwomenwithpathogenicdystrophingenevariants
AT henningbundgaard cardiacinvolvementinwomenwithpathogenicdystrophingenevariants
AT johnvissing cardiacinvolvementinwomenwithpathogenicdystrophingenevariants